Location History:
- La Habana, CU (2015)
- Playa la Habana, CU (2018)
Company Filing History:
Years Active: 2015-2018
Title: Viviana Falcón Cama: Innovator in Antiviral Peptide Research
Introduction
Viviana Falcón Cama is a prominent inventor based in Playa La Habana, Cuba. She has made significant contributions to the field of biotechnology, particularly in the development of antiviral peptides. With a total of two patents to her name, her work focuses on innovative methods to combat viral infections.
Latest Patents
Her latest patents include "Beta hairpin peptides having antiviral properties against Dengue virus." This invention discloses structurally constrained synthetic peptides optimized for forming a beta hairpin structure. These peptides are capable of inhibiting or attenuating Dengue virus (DENV) infections. The invention also includes pharmaceutical compositions containing these synthetic peptides, which are useful for preventing and treating DENV-caused infections. Additionally, she has developed a "Method for inhibiting HIV replication in mammal and human cells." This method describes how to inhibit the replication of the human immunodeficiency virus (HIV) by negatively modulating the cytoskeleton, specifically targeting proteins such as vimentin and keratin-10. The invention provides means and methods for altering the cytoskeleton structure of cells, which can disturb and potentially inhibit HIV infection.
Career Highlights
Viviana has worked with notable institutions, including the Centro de Ingeniería Genética y Biotecnología. Her research has been pivotal in advancing the understanding of antiviral mechanisms and developing therapeutic strategies against viral infections.
Collaborations
She has collaborated with esteemed colleagues such as Osvaldo Reyes Acosta and Glay Chinea Santiago, contributing to a rich environment of innovation and research.
Conclusion
Viviana Falcón Cama's work exemplifies the intersection of science and innovation in the fight against viral diseases. Her contributions to antiviral peptide research are invaluable and continue to inspire future advancements in biotechnology.